{"result": {"id": "c780616c-cd03-4cef-9f8d-57b29c64fa61", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>URAPIDIL<|>ORGANIZATION<|>Urapidil is a medication used for controlling blood pressure in acute ischemic stroke patients before treatment)\n##\n(\"entity\"<|>LABETALOL<|>ORGANIZATION<|>Labetalol is a medication used for controlling blood pressure in acute ischemic stroke patients before treatment)\n##\n(\"entity\"<|>NICARDIPINE<|>ORGANIZATION<|>Nicardipine is a medication used for controlling blood pressure in acute ischemic stroke patients before treatment)\n##\n(\"entity\"<|>CCB<|>ORGANIZATION<|>Calcium channel blockers are a class of medications used for controlling blood pressure in hypertension subemergency cases)\n##\n(\"entity\"<|>ACEI<|>ORGANIZATION<|>Angiotensin-converting enzyme inhibitors are a class of medications used for controlling blood pressure in hypertension subemergency cases)\n##\n(\"entity\"<|>ARB<|>ORGANIZATION<|>Angiotensin receptor blockers are a class of medications used for controlling blood pressure in hypertension subemergency cases)\n##\n(\"entity\"<|>Α RECEPTOR BLOCKER<|>ORGANIZATION<|>Alpha receptor blockers are a class of medications used for controlling blood pressure in hypertension subemergency cases)\n##\n(\"entity\"<|>Β RECEPTOR BLOCKER<|>ORGANIZATION<|>Beta receptor blockers are a class of medications used for controlling blood pressure in hypertension subemergency cases)\n##\n(\"entity\"<|>LOOP DIURETIC<|>ORGANIZATION<|>Loop diuretics are a class of medications used for controlling blood pressure in hypertension subemergency cases)\n##\n(\"relationship\"<|>URAPIDIL<|>LABETALOL<|>Both Urapidil and Labetalol are used for controlling blood pressure in acute ischemic stroke patients before treatment<|>5)\n##\n(\"relationship\"<|>URAPIDIL<|>NICARDIPINE<|>Both Urapidil and Nicardipine are used for controlling blood pressure in acute ischemic stroke patients before treatment<|>5)\n##\n(\"relationship\"<|>LABETALOL<|>NICARDIPINE<|>Both Labetalol and Nicardipine are used for controlling blood pressure in acute ischemic stroke patients before treatment<|>5)\n##\n(\"relationship\"<|>CCB<|>ACEI<|>Both CCB and ACEI are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n##\n(\"relationship\"<|>CCB<|>ARB<|>Both CCB and ARB are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n##\n(\"relationship\"<|>CCB<|>Α RECEPTOR BLOCKER<|>Both CCB and Alpha receptor blockers are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n##\n(\"relationship\"<|>CCB<|>Β RECEPTOR BLOCKER<|>Both CCB and Beta receptor blockers are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n##\n(\"relationship\"<|>CCB<|>LOOP DIURETIC<|>Both CCB and Loop diuretics are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n##\n(\"relationship\"<|>ACEI<|>ARB<|>Both ACEI and ARB are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n##\n(\"relationship\"<|>ACEI<|>Α RECEPTOR BLOCKER<|>Both ACEI and Alpha receptor blockers are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n##\n(\"relationship\"<|>ACEI<|>Β RECEPTOR BLOCKER<|>Both ACEI and Beta receptor blockers are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n##\n(\"relationship\"<|>ACEI<|>LOOP DIURETIC<|>Both ACEI and Loop diuretics are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n##\n(\"relationship\"<|>ARB<|>Α RECEPTOR BLOCKER<|>Both ARB and Alpha receptor blockers are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n##\n(\"relationship\"<|>ARB<|>Β RECEPTOR BLOCKER<|>Both ARB and Beta receptor blockers are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n##\n(\"relationship\"<|>ARB<|>LOOP DIURETIC<|>Both ARB and Loop diuretics are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n##\n(\"relationship\"<|>Α RECEPTOR BLOCKER<|>Β RECEPTOR BLOCKER<|>Both Alpha and Beta receptor blockers are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n##\n(\"relationship\"<|>Α RECEPTOR BLOCKER<|>LOOP DIURETIC<|>Both Alpha receptor blockers and Loop diuretics are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n##\n(\"relationship\"<|>Β RECEPTOR BLOCKER<|>LOOP DIURETIC<|>Both Beta receptor blockers and Loop diuretics are classes of medications used for controlling blood pressure in hypertension subemergency cases<|>5)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558810, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 1257, "prompt_tokens": 2413, "total_tokens": 3670, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 621}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: � ≥110 mmHg开始降压治  疗[522] 。对于拟进行静脉溶栓及血管内治疗的急性缺  血性 脑 卒 中 患 者 , 建 议 在 治 疗 前 控 制 血 压 ≤180/ 100mmHg,选用乌拉地尔、拉贝洛尔、尼卡地平等静\n\n\n\n\n脉药物[522] 。\n　　　高血压合并急性出血性脑卒中 :应先综合评估患 者的血压 ,分析血压升高的原因 ,再根据血压情况决定 是否进 行 降 压 治 疗 。建 议 急 性 期 将 收 缩 压 控 制 在 130~140mmHg。早期积极降压是安全的 ,但改善预 后的有效性还有待进一步验证 。在降压治疗期间应严 密观察血压的变化。\n重度子痫前期或子痫、儿茶酚胺危象初始 1 h血\n\n\n\n压控制目标收缩压<140mmHg。\n　　　注意事项 :高血压急症的血压控制是在保证重要 脏器灌注基础上的迅速降压 。降压过程中要严密观察 靶器官功能状况 ,如神经系统症状和体征的变化和胸 痛是否加重等 。对于已经存在靶器官损害者 ,过快或 过度降压容易导致组织灌注压降低 ,诱发缺血事件。\n　11.2.2  高血压亚急症的治疗    对高血压亚急症患  者 ,可在 24~48h将血压缓慢降至 160/100mmHg。 没有证据说明此种情况下紧急降压治疗可以改善预  后 。许多高血压亚急症患者可通过口服降压药控制 ,  如 CCB、ACEI、ARB、α受体阻滞剂、β受体阻滞剂等 ,  还可根据情况应用袢利尿剂 。初始治疗可以在门诊或  急诊室 ,用药后观察 5~ 6 h。2~ 3 d后门诊调整剂  量 ,此后可应用长效药物控制至最终的靶目标血压。 到急诊就诊的高血压亚急症患者在血压初步控制后 ,  应提出调整口服药物治疗的建议 ,并建议患者定期去  门诊治疗 。许多患者因为不明确需要调整药物 ,在急  诊就诊后仍维持原来未达标的治疗方案 ,造成高血压  亚急症的反复发生 ,最终导致严重的后果 。具有高危  因素的高血压亚急症 ,如伴有心血管疾病的患者也可  以住院治疗。\n\n12  社区高血压防治策略及规范化管理\n\n要点 12  社区高血压防治策略及规范化管理\n　　　·及时检出高血压是防治的第一步 。在社区及 基层医疗卫生机构建立 “首诊测血压”制度并提供机 会性测血压的条件。\n　　　·将高血压患者管理融入全科医生日常医疗工 作中 ,建立以全科医生为主体的高血压分级诊治体系 以保持\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_4c57e940a1b03341e99fcc05b6afd6f0646915b40c06e32158a1ef5b5daeed4f_v2"}